US Approves NVDA H200 Sales to 10 Chinese Companies, Easing Supply Constraints
The US government greenlit NVIDIA H200 chip exports to 10 Chinese companies, easing prior restrictions and signaling a potential thaw in US-China tech tensions during Trump's Beijing summit. This moves NVDA higher as investors price in expanded addressable market and higher chip demand.
RKey facts
- US government approved NVIDIA H200 chip sales to 10 Chinese companies
- Jensen Huang attended Trump-Xi state banquet in Beijing on May 14
- NVDA shares moved higher on the news, extending week's 20% rally
- H200 is NVIDIA's flagship inference accelerator for AI workloads
What's happening
NVIDIA shares rallied on the heels of US government approval for H200 chip sales to Chinese buyers, a significant policy shift that stands in stark contrast to months of export restrictions that have weighed on the chipmaker. The timing coincides with President Trump's high-profile state visit to Beijing alongside NVIDIA CEO Jensen Huang and other tech executives. Market participants interpreted the approval as a signal that the US-China relationship may be softening on critical semiconductors, at least in the near term.
The H200 is NVIDIA's flagship accelerator chip for AI inference workloads, one of the most coveted pieces of hardware in the current AI buildout. Approval to sell to 10 named Chinese firms removes a regulatory overhang that had constrained NVIDIA's growth guidanceCompany-issued forecasts of future financial performance. and left demand unmet. Multiple sources noted that Chinese buyers have been desperate for these chips; the government's willingness to permit sales suggests either a negotiated trade-off tied to farm and oil trade discussions, or a broader strategic recalibration ahead of a Trump second term.
For equities, the narrative centers on NVIDIA's ability to expand margins and revenue in a previously gated market. AVGO, ARM, and other semiconductor names that benefit from AI deployment also rode the coattails of the news. The approval removes downside risk to the mega-cap tech rally that has driven SPY and QQQ to fresh records; it also reinstates upside optionality for China-exposed suppliers. JPMorgan and other strategists have noted that broadening the geographic base for AI capex, beyond the US, is critical to extending the bull case for semiconductor and networking stocks.
Skeptics point out that one policy announcement does not make a structural trade thaw; the broader export regime remains restrictive, and future administrations could reverse course. Additionally, 10 customers is a modest number relative to NVIDIA's total addressable market, and the geopolitical risk premium on tech stocks will likely persist as long as Taiwan remains a flashpoint.
What to watch next
- 01Trump-Xi summit outcome on trade and tech negotiations: today/next week
- 02NVIDIA earnings guidanceCompany-issued forecasts of future financial performance. on China revenue and H200 demand: coming weeks
- 03US export license reviews for broader semiconductor categories: ongoing
- PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Angi Inc. - ANGI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Angi Inc. ("Angi" or the "Company") (NASDAQ: ANGI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns...
17m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of BayCom Corp - BCML
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of BayCom Corp ("BayCom" or the "Company") (NASDAQ: BCML). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
17m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc. - SMTI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sanara MedTech, Inc. ("Sanara" or the "Company") (NASDAQ: SMTI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
17m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Forward Air Corporation - FWRD
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Forward Air Corporation ("Forward Air" or the "Company") (NASDAQ: FWRD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
17m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Replimune Group, Inc. ("Replimune" or the "Company") (NASDAQ: REPL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
17m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Veritone, Inc. - VERI
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Veritone, Inc. ("Veritone" or the "Company") (NASDAQ: VERI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
17m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ: ADMA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation...
17m ago - PR Newswire FinancialINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nano-X Imaging Ltd. - NNOX
NEW YORK, May 14, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Nano-X Imaging Ltd. ("Nano-X" or the "Company") (NASDAQ: NNOX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The...
17m ago
Related coverage
- NVDA Hits Record $6 Trillion Valuation After 20% Rally; Peak Debate IntensifiesTech & AI··0 mentions
- NVIDIA H200 Chips Approved for 10 Chinese Companies Amid Trump-Xi SummitTech & AI··0 mentions
- S&P 500, Nasdaq Hit Fresh Records on AI Momentum and Retail DataEquities US··0 mentions
- Cerebras IPO Surges 89% Above Listing; AI Chipmaker Valuation Breakout Signals Sector MomentumTech & AI··0 mentions
More about $NVDA
- Cerebras IPO Soars 89% Above Listing; AI Chip Demand Drives $5.55 Billion Raise·Tech & AI
- US Approves NVDA H200 Chip Sales to 10 Chinese Companies; Jensen Huang in Beijing·Tech & AI
- Cerebras IPO Surges 89% on AI Chipmaker Demand; $5.55B Haul Beats Estimates·Tech & AI
- Top 10 US Stocks at Record Concentration; Active Managers Lag Mega-Cap Rally·Equities US
- S&P 500, Nasdaq Hit Fresh Records on AI Momentum and Retail Data·Equities US
Top 10 names now over 38% of the S&P 500. What that means for SPY holders, passive flows and tail risk.